GlassScriptPhysician profile
Troy I Mounts
NPI 1285825018
$3,405.67
in general payments reported to CMS, 2019-2025
22 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,660 · 2020: $49.29 · 2021: $285 · 2022: $854 · 2023: $414 · 2024: $22.20 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,488.80 | 2019-2021 | |
| Alphatec Spine, INC | $824.03 | 2020-2022 | |
| Medtronic, INC. | $389.97 | 2021-2023 | Catalyft Pl Expandable Interbody System, Mazor X System |
| Xtant Medical INC | $121.53 | 2025 | |
| Osseus Fusion Systems, LLC | $119.24 | 2019 | |
| Medtronic USA, INC. | $55.28 | 2019 | |
| Sanara Medtech INC. | $47.13 | 2021 | |
| Si-Bone, INC. | $36.07 | 2021-2022 | |
| Ctl Medical Corporation | $34.50 | 2021 | |
| Abbott Laboratories | $31.04 | 2022 | |
| Alnylam Pharmaceuticals INC. | $28.88 | 2021 | |
| Abbvie INC. | $27.47 | 2021-2023 | |
| Nevro Corp. | $26.98 | 2023 | Senza |
| Titan Spine, LLC | $23.47 | 2019 | |
| Organogenesis INC. | $22.61 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $22.20 | 2024 | Horizant |
| Averitas Pharma INC. | $21.35 | 2023 | Qutenza |
| Zimvie INC. | $19.55 | 2023 | |
| Relievant Medsystems, INC. | $19.11 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.81 | 2021 | |
| Baudax Bio INC. | $15.58 | 2020 | |
| Vertiflex, INC. | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Mounts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.